Operose Advisors’s Idexx Laboratories IDXX Stock Holding History

Operose Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-331	Closed	-$145K	–	666
2023 Q3	$145K	Buy	+331	New	+$165K	0.06%	172

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Operose Advisors's IDXX Position: Q4 2023 in Review

Operose Advisors sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 331 shares — an estimated $145K sold.

Operose Advisors first reported a position in IDXX in Q3 2023 and held it in 1 quarter. The position peaked at $145K in Q3 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Operose Advisors reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 331 Idexx Laboratories shares in Q4 2023, an estimated $145K.
Operose Advisors first reported a position in Idexx Laboratories in Q3 2023 and held it in 1 quarter.
Operose Advisors's Idexx Laboratories position peaked at $145K in Q3 2023.
1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.